Zobrazeno 1 - 10
of 239
pro vyhledávání: '"Masatsugu Tanaka"'
Autor:
Natsuki Hirose, Takayoshi Tachibana, Akihiko Izumi, Shuku Sato, Noriyuki Tadera, Yotaro Tamai, Heiwa Kanamori, Masatsugu Tanaka, Hideaki Nakajima
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTObjectives and Methods This single-center retrospective study was performed to evaluate the safety and efficacy of FMS-like tyrosine kinase 3 (FLT3) inhibitors before and after allogeneic hematopoietic cell transplantation (HCT) in relapsed/r
Externí odkaz:
https://doaj.org/article/f91cf94c75a84c5eb87d94b67595d990
Autor:
Tomoyasu Jo, Yasuyuki Arai, Junya Kanda, Tadakazu Kondo, Kazuhiro Ikegame, Naoyuki Uchida, Noriko Doki, Takahiro Fukuda, Yukiyasu Ozawa, Masatsugu Tanaka, Takahide Ara, Takuro Kuriyama, Yuta Katayama, Toshiro Kawakita, Yoshinobu Kanda, Makoto Onizuka, Tatsuo Ichinohe, Yoshiko Atsuta, Seitaro Terakura
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-11 (2023)
Abstract Background Forecasting acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation (HSCT) is highly challenging with conventional statistical techniques due to complex parameters and their interactions. T
Externí odkaz:
https://doaj.org/article/7d45f5c179554d47a86525b9d7124fdc
Autor:
Hiroki Mizumaki, Ken Ishiyama, Jun Aoki, Jinichi Mori, Shohei Mizuno, Noriko Doki, Takahiro Fukuda, Naoyuki Uchida, Masahito Onizuka, Masatsugu Tanaka, Yuta Katayama, Yukiyasu Ozawa, Kazuhiro Ikegame, Satoru Takada, Toshiro Kawakita, Nobuyuki Aotsuka, Yoshiko Atsuta, Masamitsu Yanada
Publikováno v:
eJHaem, Vol 4, Iss 1, Pp 251-257 (2023)
Abstract The prognosis of acute myeloid leukemia (AML) patients with der(1;7)(q10;p10) who underwent allogeneic hematopoietic stem cell transplantation (allo‐SCT) is unclear due to its rarity. We retrospectively analyzed 151 AML patients with der(1
Externí odkaz:
https://doaj.org/article/f8c29b89765d4b6d9344c3c0455cf547
Autor:
Haruka Teshigawara-Tanabe, Maki Hagihara, Jun Aoki, Satoshi Koyama, Hiroyuki Takahashi, Yuki Nakajima, Hiroyoshi Kunimoto, Takayoshi Tachibana, Takuya Miyazaki, Kenji Matsumoto, Masatsugu Tanaka, Etsuko Yamazaki, Shin Fujisawa, Heiwa Kanamori, Masataka Taguri, Hideaki Nakajima
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 620-628 (2022)
Objectives: Allogeneic hematopoietic stem cell transplantation (allo-HCT) is the only curative treatment for myelodysplastic syndromes (MDS), although predicting post-transplant outcomes remains inconclusive. This study evaluated patients who underwe
Externí odkaz:
https://doaj.org/article/52c7e0daf709498f9f99e3569e47dd0b
Autor:
Yukiko Misaki, Masaharu Tamaki, Ryu Yanagisawa, Noriko Doki, Takahiro Fukuda, Naoyuki Uchida, Masatsugu Tanaka, Yukiyasu Ozawa, Masashi Sawa, Takahide Ara, Junya Kanda, Yoshiko Atsuta, Yoshinobu Kanda, Hideki Nakasone
Publikováno v:
HemaSphere, Vol 7, p e5442011 (2023)
Externí odkaz:
https://doaj.org/article/34ba38e12ffb44ab8dfa6607774040c8
Autor:
Masaharu Tamaki, Yu Akahoshi, Yosuke Okada, Naoyuki Uchida, Masatsugu Tanaka, Noriko Doki, Masashi Sawa, Yumiko Maruyama, Yasunori Ueda, Shigesaburo Miyakoshi, Yuta Katayama, Toshiro Kawakita, Takafumi Kimura, Makoto Onizuka, Takahiro Fukuda, Yoshiko Atsuta, Ryu Yanagisawa, Kimikazu Yakushijin, Junya Kanda, Hideki Nakasone
Publikováno v:
HemaSphere, Vol 7, p e35145ae (2023)
Externí odkaz:
https://doaj.org/article/78a2ce76c0d142f08407ce4d316fdd9a
Autor:
Shigeo Fuji, Akitoshi Hakoda, Junya Kanda, Takahiro Fukuda, Noriko Doki, Yuta Katayama, Naoyuki Uchida, Yukiyasu Ozawa, Yoshinobu Kanda, Masatsugu Tanaka, Keisuke Kataoka, Takahide Ara, Masashi Sawa, Makoto Onizuka, Yasushi Onishi, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, Ayumi Shintani, Satoko Morishima
Publikováno v:
HemaSphere, Vol 7, p e0799573 (2023)
Externí odkaz:
https://doaj.org/article/ca7d6ed0ed1d4941ac0d6d84354031ca
Autor:
Satoshi Nishiwaki, Isamu Sugiura, Shin Fujisawa, Yoshihiro Hatta, Yoshiko Atsuta, Noriko Doki, Shingo Kurahashi, Yasunori Ueda, Nobuaki Dobashi, Tomoya Maeda, Yasuhiro Taniguchi, Masatsugu Tanaka, Shinichi Kako, Tatsuo Ichinohe, Takahiro Fukuda, Shigeki Ohtake, Yuichi Ishikawa, Hitoshi Kiyoi, Itaru Matsumura, Yasushi Miyazaki, on behalf of Japan Adult Leukemia Study Group
Publikováno v:
HemaSphere, Vol 7, Iss 6, p e899 (2023)
Externí odkaz:
https://doaj.org/article/d7e5a0987ca542338d175708144ea6e9
Autor:
Takayoshi Tachibana, Masatsugu Tanaka, Yuma Noguchi, Yuho Najima, Daichi Sadato, Yuka Harada, Yotaro Tamai, Noriko Doki, Hideaki Nakajima
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
The outcomes of relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) resistant to new drugs such as tyrosine kinase inhibitors, inotuzumab ozogamicin (InO) and blinatumomab are dismal. We treated two cases of Ph+ALL resista
Externí odkaz:
https://doaj.org/article/0209de57f1fb4edd864fcf22b274fc1b
Autor:
Takaaki Konuma, Shohei Mizuno, Tadakazu Kondo, Yasuyuki Arai, Naoyuki Uchida, Satoshi Takahashi, Masatsugu Tanaka, Takuro Kuriyama, Shigesaburo Miyakoshi, Makoto Onizuka, Shuichi Ota, Yasuhiro Sugio, Yasushi Kouzai, Toshiro Kawakita, Hikaru Kobayashi, Yukiyasu Ozawa, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, Masamitsu Yanada, for the Adult Acute Myeloid Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 5, Pp 1-12 (2022)
Abstract Unrelated cord blood transplantation (CBT) is an alternative curative option for adult patients with acute myeloid leukemia (AML) who need allogeneic hematopoietic cell transplantation (HCT) but lack an HLA-matched related or unrelated donor
Externí odkaz:
https://doaj.org/article/660bfbb942e140e3b2a59f19b7d5883d